Figure 1 . Circulating CXCL16 concentrations in the patients with sepsis were increased. (A) Soluble levels of serum CXCL16 in 55 septic patients and 30 healthy controls. (B) The dynamics of soluble CXCL16 levels in the serum of patients with sepsis. (C) Soluble CXCL16 levels in the serum collected from patients with septic shock and patients without shock on day of ICU admission. (D) Soluble CXCL16 levels in the serum collected from septic survivors and nonsurvivors. Nonparametric Mann–Whitney U test or Kruskal-Wallis test followed by Dunn’s multiple comparisons post test was performed to analyze results between groups. Horizontal bars represent median values, and dots represent individual participants.